Learning Zone Feedback

Declaration of sponsorship Pfizer

Last updated:24th Jul 2023

Published:24th Jul 2023

Roundtable: mCRPC update 2024
mCRPC: Challenges and treatments
Expert opinions on mCRPC management
Congress highlights
Podcast series: What’s new in mCRPC?
Meet the experts
Learning Zone Feedback

Thank you for yor feedback

Did you catch our videos with Axel Merseburger, Karim Fizazi and Neeraj Agarwal on mCRPC management? Access via the link below

View now

I have improved my management of mCRPC as a result of the ‘Responding to unmet needs for metastatic castration-resistant prostate cancer’ Learning Zone

Strongly agree

Agree

Neutral

Disagree

Strongly disagree

As a result of this Learning Zone, I have made changes to my clinical practice

Strongly agree

Agree

Neutral

Disagree

Strongly disagree

Please describe any changes you have made

Applying what I’ve learned from this Learning Zone has helped improve patient outcomes

Strongly agree

Agree

Neutral

Disagree

Strongly disagree

Do you have any additional comments related to the ‘Responding to unmet needs for metastatic castration-resistant prostate cancer’ Learning Zone

Please tick this box if you are willing to be contacted by the Head of our Scientific Services team for a brief follow-up discussion

I agree

Developed by EPG Health. This content has been developed independently of the sponsor, Pfizer, which has had no editorial input into the content. EPG Health received funding from the sponsor to help provide healthcare professional members with access to the highest quality medical and scientific information, education and associated relevant content. This content is intended for healthcare professionals only.

Personalised to support your treatment decisions

Specialty
Congress
News & Insights
Education
About us